The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. 

Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.

Clinical Trials

Life Sciences

Immune Tolerance Network

Mark Anderson

James Connelly

Audrey Plough Msn

Philip Bernstein

Jared Hennessy

Dawn Smilek

The Research and Data Analysis team at the Immune Tolerance Network focuses on harnessing and interpreting complex data from clinical trials and laboratory studies to drive advancements in immune tolerance therapies. This team collaborates with researchers and stakeholders to identify key biomarkers, develop robust data architectures, and ensure the integrity of data analysis, ultimately facilitating informed decision-making in the design and execution of innovative treatment strategies for various immune-related disorders.

Research and Data Analysis

Clinical Operations Team

Research and Data Analysis

About

Team members

Other teams at Immune Tolerance Network

Clinical Operations Team